Đang chuẩn bị liên kết để tải về tài liệu:
ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Excision Repair Cross-Complementation group 6-like (ERCC6L) has been shown to exhibit carcinogenic effect in several malignant tumors. However, the function and molecular mechanism of the ERCC6L in hepatocellular carcinoma (HCC) have not been investigated extensively. |